Viridien stock climbs nearly 5%, leading the SBF 120 gainers
Viridien is among the strongest gainers of the SBF 120 during midday trading on Tuesday, September 1st, in a declining Paris market. Goldman Sachs initiated coverage of the stock today with a buy rating and a price target of €118, representing an upside potential of nearly 28% compared to the current price.
Goldman Sachs initiates buy coverage with a €118 price target
This morning, Goldman Sachs launched its coverage on Viridien with a buy rating and a target of €118. This level represents an upside potential of approximately 28% compared to the €92 trading price during the session, which starkly contrasts with the stock's quarterly trajectory, down more than 23% over three months. The market reaction is immediate: the stock gains 4.78% during trading, ranking among the strongest gainers of the SBF 120, while the index declines 0.51%.
This positioning by a major global brokerage firm comes in a context where Viridien is seeking to improve its operational performance. When publishing Q1 2026 results (May 5, 2026), the group had confirmed its net cash flow generation target of 100 million dollars for the fiscal year, with seasonality comparable to that of 2025. The second quarter 2026 results published on July 30 had furthermore shown a net half-year cash flow in sharp progression at 32 million dollars, despite a 22% decline in revenue.
A technical rebound that consolidates the position above key moving averages
From a technical perspective, today's gain extends and amplifies the movement initiated the previous week, with the stock posting a 7.6% gain over seven days. The price of €92 stands above the 20-day MA (€90.55, +1.60% difference) and well above the 50-day MA (€85.44, +7.68% difference), two levels the stock had recovered during the previous session's rebound. Conversely, the 200-day MA at €108.60 remains 15.29% above the current price, underscoring that medium-term momentum remains deteriorated despite the recent improvement. The RSI at 49 is in neutral territory, without overbought signals, which technically leaves room before a potential resistance at €99.40.
Furthermore, according to consulted declarations, net cumulative short positions reach 6.50% of capital, distributed among eight funds, up 1.62 points over thirty days. This elevated level testifies to a still significant institutional bearish bet on the stock: it does not call into question today's movement, but reminds that selling conviction remains present on the stock. The analyst consensus now benefits from a buy rating from Goldman Sachs, targeting €118, which is the next resistance level to monitor beyond the immediate €99.40.
